跳至主要内容
临床试验/JPRN-UMIN000014591
JPRN-UMIN000014591已完成1 期

Phase 1/2 trial of TAME(:Transcatheter arterial micro embolization) for chronic musculoskeletal pain refractory to non-surgical management - TAME Phase 1/2 study

Edogawa Musculoskeletal Intervention Study Group0 个研究点目标入组 33 人开始时间: 2014年7月20日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Reheumatoid arthritis 2.Neoplasm 3.Severe arteriosclerosis 4.Pregnant female 5.Dementia 6.Complaining joint instability 7.Iodine Allergy 8.Patients with severe cardiac disease, cerebrovascular disease, neurological disease, uncontrollable diabetic mellitus and hypertension, severe infection, intestinal bleeding, interstitial pneumonia, ascites fluid, pleural effusion. 9, Pain due to cervical or lumbar spine pathology 10,Patients who was decided not to be appropriate for this trial by physician

研究者

发起方
Edogawa Musculoskeletal Intervention Study Group

相似试验